Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
1994-5-5
|
pubmed:abstractText |
Regulatory volume increase (RVI) has been studied in cultured human fibroblasts (CHF) incubated in a complete hypertonic growth medium (400 mosmol/kg). After the initial cell shrinkage induced by hypertonic treatment, cells recover their volume almost completely within 3 h. This RVI response is associated with a marked increase of the cell content of free amino acids. The cell content of potassium increases only slightly. Chromatographic analysis of the intracellular amino acid pool shows that the RVI-associated increase in cell amino acids is mainly a result of changes in the L-glutamine content. The intracellular accumulation of the analog 2-methylaminoisobutyric acid, a specific substrate of transport system A, is increased in CHF undergoing RVI. Hypertonic treatment causes an immediate and sustained cell hyperpolarization, as demonstrated by changes in the trans-membrane distribution ratio of L-arginine and in the fluorescence of the potential-sensitive dye bis-1,3-diethylthiobarbiturate-trimethineoxonol. Because of cell hyperpolarization, at the end of RVI the trans-membrane gradient of the sodium electrochemical potential is higher than that of the control. The increase in the extracellular potassium concentration ([K+]out = 40 mM) abolishes the hyperpolarization induced by hypertonic treatment and delays volume recovery. Cycloheximide suppresses RVI at a high but not at physiologic [K+]out. It is proposed that CHF counteract hypertonic shrinkage through an enhanced accumulation of substrates of transport system A sustained, initially, by an increase in the energy available for transport and, subsequently, also by the synthesis of new site A carriers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
269
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10485-91
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8144632-Adolescent,
pubmed-meshheading:8144632-Amino Acids,
pubmed-meshheading:8144632-Biological Transport, Active,
pubmed-meshheading:8144632-Cell Size,
pubmed-meshheading:8144632-Cells, Cultured,
pubmed-meshheading:8144632-Fibroblasts,
pubmed-meshheading:8144632-Humans,
pubmed-meshheading:8144632-Hypertonic Solutions,
pubmed-meshheading:8144632-Male,
pubmed-meshheading:8144632-Membrane Potentials,
pubmed-meshheading:8144632-Osmolar Concentration,
pubmed-meshheading:8144632-Potassium,
pubmed-meshheading:8144632-Protein Biosynthesis,
pubmed-meshheading:8144632-Sodium
|
pubmed:year |
1994
|
pubmed:articleTitle |
Response of human fibroblasts to hypertonic stress. Cell shrinkage is counteracted by an enhanced active transport of neutral amino acids.
|
pubmed:affiliation |
Istituto di Patologia Generale, Università degli Studi di Parma, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|